Alexza off after migraine miss

Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) fell $0.34 (12%) to $2.56 on Monday after preliminary data showed inhaled AZ-104 ( Staccato loxapine) missed the primary endpoint of pain relief at two hours ...